Why the study?
Does empiric amiodarone reduce the recurrence of VT/VF compared to ineffective drug therapy in patients with drug-refractory ventricular tachyarrhythmias?
Population
77 patients with spontaneous, symptomatic ventricular tachyarrhythmias and persistently inducible VT during…
Comparison
Empiric amiodarone (AM) vs Drugs predicted during electrophysiological…
Design
Cohort
Follow-up
15.7 ± 11.0 months for amiodarone; 17.8 ± 10.8 months for…
Authors
Loading...
May delay early VT/VF recurrence with empiric amiodarone; leaves open long-term benefit versus ineffective drugs in observational data.
Does empiric amiodarone reduce the recurrence of VT/VF compared to ineffective drug therapy in patients with drug-refractory ventricular tachyarrhythmias?
Empiric amiodarone delays the onset of recurrent VT/VF but does not reduce the ultimate long-term incidence compared to ineffective drug therapy in patients with refractory ventricular tachyarrhythmias.
Fogoros et al. (1988) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: